Skip to main content
. 2013 Sep 30;75(3):104–110. doi: 10.4046/trd.2013.75.3.104

Figure 2.

Figure 2

Receiver operating characteristic curve analysis of the plasma osteopontin levels in the non-small cell lung cancer patients and controls.